Evidence map›Paper›PMID 30306351›Full record

ReviewCurrent psychiatry reports2018

Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.

Hillary B Nguyen, Alexis M Chavez, Emily Lipner, Liisa Hantsoo, Sara L Kornfield, Robert D Davies, C Neill Epperson

Open access · greenAbstract readReview
In one paragraph

Review in Current psychiatry reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 2 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hillary B NguyenSchool of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Alexis M ChavezDepartment of Psychiatry, University of Colorado School of Medicine-Anschutz Medical Campus, 13001 E 17th Place, MS F546, Aurora, CO, 80045, USA.
Emily LipnerPenn PROMOTES Research on Sex and Gender in Health, University of Pennsylvania, Philadelphia, PA, USA.
Liisa HantsooDepartment of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Sara L KornfieldDepartment of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Robert D DaviesDepartment of Psychiatry, University of Colorado School of Medicine-Anschutz Medical Campus, 13001 E 17th Place, MS F546, Aurora, CO, 80045, USA.
C Neill EppersonPenn PROMOTES Research on Sex and Gender in Health, University of Pennsylvania, Philadelphia, PA, USA. neill.epperson@ucdenver.edu.
University of Pennsylvania · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Psychophysiology, Neurosteroids, and Stress in Premenstrual Dysphoric Disorder (PMDD)K23MH107831 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI HANTSOO, LIISA VICTORIA · 2016 to 2020
$905k
PTSD AND PREGNANCY: PSYCHOPHYSIOLOGY, RESPONSE TO TREATMENT & PREGNANCY OUTCOMEK23MH102360 · NIMH · WASHINGTON UNIVERSITY · PI KORNFIELD, SARA L. · 2014 to 2018
$675k
NIMH NIH HHS K23 MH102360NIMH NIH HHS K23 MH107831
6 · The paper itself

Abstract

purpose of reviewWith increasing numbers of transgender and gender non-binary individuals presenting for care, knowing how to elucidate the mental health and cognitive outcomes of gender-affirming hormone therapy (GAHT) is necessary. This article reviews the present literature covering GAHT effects on mood, behavioral health, and cognition in these individuals and offers research priorities to address knowledge gaps. RECENT

findingsAlthough there are some conflicting data, GAHT overwhelmingly seems to have positive psychological effects in both adolescents and adults. Research tends to support that GAHT reduces symptoms of anxiety and depression, lowers perceived and social distress, and improves quality of life and self-esteem in both male-to-female and female-to-male transgender individuals. Clinically, prescribing GAHT can help with gender dysphoria-related mental distress. Thus, timely hormonal intervention represents a crucial tool for improving behavioral wellness in transgender individuals, though effects on cognitive processes fundamental for daily living are unknown. Future research should prioritize better understanding of how GAHT may affect executive functioning.

Indexed as

Gender IdentityMental HealthQuality of LifeCognitionDepressionFemaleGender DysphoriaGonadal Steroid HormonesHumansMaleSelf ConceptTransgender PersonsTranssexualismGonadal Steroid HormonesBehavioral healthCognitionGenderGender-affirming hormone therapyMoodSexTransgender

Identifiers

PMID30306351
PMCPMC6354936
OpenAlexW2896444596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.